CoChat

Role of the hemopexin domain of matrix metalloproteinases in cell migration

Open access
Dufour, Antoine, Sampson, Nicole S., Zucker, Stanley, Cao, Jian · 2008 · Journal of Cellular Physiology
Cited by 153

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The biological functions of matrix metalloproteinases (MMPs) extend beyond extracellular matrix degradation. Non‐proteolytic activities of MMPs are just beginning to be understood. Herein, we evaluated the role of proMMPs in cell migration. Employing a Transwell chamber migration assay, we demonstrated that transfection of COS‐1 cells with various proMMP cDNAs resulted in enhancement of cell migration. Latent MMP‐2 and MMP‐9 enhanced cell migration to a greater extent than latent MMP‐1, ‐3, ‐11 and ‐28. To examine if proteolytic activity is required for MMP‐enhanced cell migration, three experimental approaches, including fluorogenic substrate degradation assay, transfection of cells with catalytically inactive mutant MMP cDNAs, and addition of hydroxamic acid‐derived MMP inhibitors, were employed. We demonstrated that the proteolytic activities of MMPs are not required for MMP‐induced cell migration. To explore the mechanism underlying MMP‐enhanced cell migration, structure‐function relationship of MMP‐9 on cell migration was evaluated. By using a domain swapping approach, we demonstrated that the hemopexin domain of proMMP‐9 plays an important role in cell migration when examined by a transwell chamber assay and by a phagokinetic migration assay. TIMP‐1, which interacts with the hemopexin domain of proMMP‐9, inhibited cell migration, whereas TIMP‐2 had no effect. Employing small molecular inhibitors, MAPK and PI3K pathways were found to be involved in MMP‐9‐mediated cell migration. In conclusion, we demonstrated that MMPs utilize a non‐proteolytic mechanism to enhance epithelial cell migration. We propose that hemopexin homodimer formation is required for the full cell migratory function of proMMP‐9. J. Cell. Physiol. 217: 643–651, 2008. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcp.21535

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • New functions for the matrix metalloproteinases in cancer progression

    Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108 · cited 1×

    “…MMP-9 to degrade ECM collagens and laminin and its ability to regulate cell migration, increase angiogenesis, and affect tumor growth (Sternlicht and Werb, 2001; Egeblad and Werb, 2002; Opdenakker and Van Damme, 2002; Sanceau et al., 2003; Bjorklund and Koivunen, 2005; Burg-Roderfeld et al., 2007).”
    Background
  • How Matrix Metalloproteinases Regulate Cell Behavior

    Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959 · cited 7×

    “The PEX domain of MMP-9 is known to bind to several cell surface molecules including LRP-1, LRP-2, CD44, RECK, Ku, and type IV collagen (Sternlicht and Werb, 2001; Monferran et al., 2004; Van den Steen et al., 2006), but the precise roles of these interactions remains speculative.”
    BackgroundResultInfluential
  • SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

    Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558 · cited 1×

    “These latter results link the JNK pathway primarily to the basal level of cell migration (Bennett et al., 2001).”
    Background

Cited by

See all 153

Metadata

Authors
Dufour, A., Sampson, N. S., Zucker, S., & Cao, J.
Venue
Journal of Cellular Physiology
Publisher
Wiley
Published
2008-07-17
Volume
217
Issue
3
Pages
643-651
ISSN
  • 0021-9541 (ISSN-L)
  • 1097-4652
OpenAlex
W2032416845
Cited by
153
References
3
FWCI
2.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.